Roche first-quarter sales up
Pharmaceutical group Roche has announced a six per cent rise in first-quarter sales to SFr7.37 billion.
This content was published on April 16, 2002 - 09:45
The company expects mid to high single digit growth to continue for the remainder of the year.
Sales in Roche's drug division rose five percent, when expressed in Swiss francs, while its diagnostics businesses yielded 9 percent.
Franz Humer, Roche's CEO, rejected speculation that the company was preparing a merger with drug giant Novartis.
swissinfo with agencies
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here. Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.